P3 Health Partners Inc. (PIIIW)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
P3 Health Partners Statistics
Share Statistics
P3 Health Partners has 3.72B shares outstanding. The number of shares has increased by 60.92% in one year.
Shares Outstanding | 3.72B |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | 77.58% |
Owned by Institutions (%) | n/a |
Shares Floating | 2.09B |
Failed to Deliver (FTD) Shares | - |
FTD / Avg. Volume | -% |
Short Selling Information
The latest short interest is 0, so 0% of the outstanding shares have been sold short.
Short Interest | 0 |
Short % of Shares Out | 0% |
Short % of Float | 0% |
Short Ratio (days to cover) | 0 |
Valuation Ratios
The PE ratio is -2.15 and the forward PE ratio is null.
PE Ratio | -2.15 |
Forward PE | null |
PS Ratio | 0.1 |
Forward PS | null |
PB Ratio | 0.87 |
P/FCF Ratio | -1.6 |
PEG Ratio | n/a |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for P3 Health Partners Inc..
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.55, with a Debt / Equity ratio of 0.86.
Current Ratio | 0.55 |
Quick Ratio | 0.57 |
Debt / Equity | 0.86 |
Total Debt / Capitalization | 46.18 |
Cash Flow / Debt | -0.62 |
Interest Coverage | -10.5 |
Financial Efficiency
Return on equity (ROE) is -0.41% and return on capital (ROIC) is -30.66%.
Return on Equity (ROE) | -0.41% |
Return on Assets (ROA) | -0.07% |
Return on Capital (ROIC) | -30.66% |
Revenue Per Employee | 3.17M |
Profits Per Employee | -144.43K |
Employee Count | 400 |
Asset Turnover | 1.47 |
Inventory Turnover | -341.75 |
Taxes
Income Tax | 2.69M |
Effective Tax Rate | -0.01 |
Stock Price Statistics
The stock price has increased by null% in the last 52 weeks. The beta is 1.14, so P3 Health Partners 's price volatility has been higher than the market average.
Beta | 1.14 |
52-Week Price Change | null% |
50-Day Moving Average | 0.02 |
200-Day Moving Average | 0.12 |
Relative Strength Index (RSI) | 57.21 |
Average Volume (20 Days) | - |
Income Statement
In the last 12 months, P3 Health Partners had revenue of 1.27B and earned -57.77M in profits. Earnings per share was -0.61.
Revenue | 1.27B |
Gross Profit | 31.64M |
Operating Income | -167.86M |
Net Income | -57.77M |
EBITDA | -81.07M |
EBIT | -167.86M |
Earnings Per Share (EPS) | -0.61 |
Balance Sheet
The company has 36.32M in cash and 121.94M in debt, giving a net cash position of -85.62M.
Cash & Cash Equivalents | 36.32M |
Total Debt | 121.94M |
Net Cash | -85.62M |
Retained Earnings | -367.34M |
Total Assets | 833.33M |
Working Capital | -190.25M |
Cash Flow
In the last 12 months, operating cash flow was -76.03M and capital expenditures -1.83M, giving a free cash flow of -77.86M.
Operating Cash Flow | -76.03M |
Capital Expenditures | -1.83M |
Free Cash Flow | -77.86M |
FCF Per Share | -0.82 |
Margins
Gross margin is 2.5%, with operating and profit margins of -13.26% and -4.56%.
Gross Margin | 2.5% |
Operating Margin | -13.26% |
Pretax Margin | -14.51% |
Profit Margin | -4.56% |
EBITDA Margin | -6.4% |
EBIT Margin | -13.26% |
FCF Margin | -6.15% |
Dividends & Yields
PIIIW does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | n/a |
FCF Yield | n/a |
Analyst Forecast
Currently there are no analyst rating for PIIIW.
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Scores
Altman Z-Score | -0.04 |
Piotroski F-Score | 3 |